Atlas Trials

S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Clinical trial NCT00945815 · COMPLETED

Trial details

NCT number
NCT00945815
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2010-09-01
Primary completion
2013-03-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.